Stay updated on SEP-363856 in Schizophrenia: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the SEP-363856 in Schizophrenia: Efficacy & Safety Clinical Trial page.

Latest updates to the SEP-363856 in Schizophrenia: Efficacy & Safety Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision (v3.5.0) is added and the previous revision (v3.4.3) is removed in the Study Record Versions, updating the revision history.SummaryDifference0.1%

- Check26 days agoChange DetectedA new revision entry (v3.4.3) was added to the history, and the previous revision (v3.4.2) was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history, and a funding-status notice was removed; there are no changes to the trial data or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check61 days agoChange DetectedThe page history now includes a general site notice about government funding lapse and an updated revision tag (v3.4.1), while the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check68 days agoChange DetectedThe history view gains a glossary toggle and color-coded highlights (green for additions, red for deletions). Version labeling updates to v3.4.0 and the No FEAR Act data line is removed.SummaryDifference1%

- Check83 days agoChange DetectedA new history entry Revision: v3.3.4 was added and an older entry Revision: v3.3.3 was removed, both representing record-keeping updates to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SEP-363856 in Schizophrenia: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SEP-363856 in Schizophrenia: Efficacy & Safety Clinical Trial page.